BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 16861038)

  • 1. Activation-induced deaminase: light and dark sides.
    de Yébenes VG; Ramiro AR
    Trends Mol Med; 2006 Sep; 12(9):432-9. PubMed ID: 16861038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic events triggered by AID, the adverse effect of antibody diversification.
    Pérez-Durán P; de Yebenes VG; Ramiro AR
    Carcinogenesis; 2007 Dec; 28(12):2427-33. PubMed ID: 17804422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative regulation of activation-induced cytidine deaminase in B cells.
    Muto T; Okazaki IM; Yamada S; Tanaka Y; Kinoshita K; Muramatsu M; Nagaoka H; Honjo T
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2752-7. PubMed ID: 16477013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AID targeting in antibody diversity.
    Pavri R; Nussenzweig MC
    Adv Immunol; 2011; 110():1-26. PubMed ID: 21762814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation-induced cytidine deaminase: a dual role in class-switch recombination and somatic hypermutation.
    Durandy A
    Eur J Immunol; 2003 Aug; 33(8):2069-73. PubMed ID: 12884279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA targets of AID evolutionary link between antibody somatic hypermutation and class switch recombination.
    Hackney JA; Misaghi S; Senger K; Garris C; Sun Y; Lorenzo MN; Zarrin AA
    Adv Immunol; 2009; 101():163-89. PubMed ID: 19231595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of AID in tumorigenesis.
    Okazaki IM; Kotani A; Honjo T
    Adv Immunol; 2007; 94():245-73. PubMed ID: 17560277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separate domains of AID are required for somatic hypermutation and class-switch recombination.
    Shinkura R; Ito S; Begum NA; Nagaoka H; Muramatsu M; Kinoshita K; Sakakibara Y; Hijikata H; Honjo T
    Nat Immunol; 2004 Jul; 5(7):707-12. PubMed ID: 15195091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of AID-mediated sequence diversification by cis-acting determinants.
    Yang SY; Schatz DG
    Adv Immunol; 2007; 94():109-25. PubMed ID: 17560273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement of the activation-induced deaminase (AID) gene for immunoglobulin gene conversion.
    Arakawa H; Hauschild J; Buerstedde JM
    Science; 2002 Feb; 295(5558):1301-6. PubMed ID: 11847344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation.
    Basu U; Chaudhuri J; Alpert C; Dutt S; Ranganath S; Li G; Schrum JP; Manis JP; Alt FW
    Nature; 2005 Nov; 438(7067):508-11. PubMed ID: 16251902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target sequence accessibility limits activation-induced cytidine deaminase activity in primary mediastinal B-cell lymphoma.
    Popov SW; Moldenhauer G; Wotschke B; Brüderlein S; Barth TF; Dorsch K; Ritz O; Möller P; Leithäuser F
    Cancer Res; 2007 Jul; 67(14):6555-64. PubMed ID: 17638864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of class switch recombination function in fish activation-induced cytidine deaminase, AID.
    Wakae K; Magor BG; Saunders H; Nagaoka H; Kawamura A; Kinoshita K; Honjo T; Muramatsu M
    Int Immunol; 2006 Jan; 18(1):41-7. PubMed ID: 16291656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone inhibits activation-induced deaminase by binding to the promoter.
    Pauklin S; Petersen-Mahrt SK
    J Immunol; 2009 Jul; 183(2):1238-44. PubMed ID: 19553525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation protects cytidines from AID-mediated deamination.
    Larijani M; Frieder D; Sonbuchner TM; Bransteitter R; Goodman MF; Bouhassira EE; Scharff MD; Martin A
    Mol Immunol; 2005 Mar; 42(5):599-604. PubMed ID: 15607819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies.
    Durandy A; Taubenheim N; Peron S; Fischer A
    Adv Immunol; 2007; 94():275-306. PubMed ID: 17560278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing AID, a physiological mutator, from deleterious activation: regulation of the genomic instability that is associated with antibody diversity.
    Nagaoka H; Tran TH; Kobayashi M; Aida M; Honjo T
    Int Immunol; 2010 Apr; 22(4):227-35. PubMed ID: 20207715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replication protein A interacts with AID to promote deamination of somatic hypermutation targets.
    Chaudhuri J; Khuong C; Alt FW
    Nature; 2004 Aug; 430(7003):992-8. PubMed ID: 15273694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation-induced cytidine deaminase in antibody diversification and chromosome translocation.
    Gazumyan A; Bothmer A; Klein IA; Nussenzweig MC; McBride KM
    Adv Cancer Res; 2012; 113():167-90. PubMed ID: 22429855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription-targeted DNA deamination by the AID antibody diversification enzyme.
    Chaudhuri J; Tian M; Khuong C; Chua K; Pinaud E; Alt FW
    Nature; 2003 Apr; 422(6933):726-30. PubMed ID: 12692563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.